Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, February 2002, p. 315-320, Vol. 46, No. 2
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.46.2.315-320.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
National Food Research Institute, Tsukuba, Ibaraki 305-8642, Japan,1 Toyama Prefectural University, Kosugi, Toyama 939-0398, Japan,2 Institute of Microbial Chemistry, Kamiosaki, Shinagawa-ku, Tokyo 141-0021, Japan3
Received 1 August 2001/ Returned for modification 7 September 2001/ Accepted 5 November 2001
We have found a novel phospholipid antibiotic (named bacilysocin) which accumulates within (or associates with) the cells of Bacillus subtilis 168 and determined the structure by nuclear magnetic resonance and mass spectrometry analyses. The structure of bacilysocin elucidated was 1-(12-methyltetradecanoyl)-3-phosphoglyceroglycerol. Bacilysocin demonstrated antimicrobial activity, especially against certain fungi. Production of bacilysocin commenced immediately after growth ceased and before the formation of heat-resistant spores. The production of bacilysocin was completely blocked when the ytpA gene, which encodes a protein homologous to lysophospholipase, was disrupted, but blockage of the ytpA gene did not significantly affect growth. Sporulation was also impaired, with a 10-fold reduction in heat-resistant spore titers being detected. Since the ytpA disruptant actually lacked phospholipase activity, we propose that the YtpA protein functions as an enzyme for the biosynthesis of bacilysocin.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»